Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MINOCA-BAT
2018-000889-11Phase 4Terminated
- Sponsor
- Department of Medical Sciences, Uppsala University
- Start
- Apr 2018
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metoprolol, bisoprolol, ramipril, enalapril, candesartan and 1 more in myocardial infarction with nonobstructive coronary arteries (MINOCA) (4 arms), sponsored by Department of Medical Sciences, Uppsala University. Primary endpoint: Primary composite endpoint. Started Apr 2018; status: terminated.
02
Drugs
metoprololbisoprololramiprilenalaprilcandesartan
03
Conditions
myocardial infarction with nonobstructive coronary arteries (MINOCA)
Beyond the preview
Go deeper on 2018-000889-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000889-11.